eli lilly sues compounders for selling unapproved copies of tirzepatide

eli lilly sues compounders for selling unapproved copies of tirzepatide telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to Lilly sues two medical spas

Name: eli lilly sues compounders for selling unapproved copies of tirzepatide telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to Lilly sues two medical spas
Brand: www.consulsalud.app
SKU: 463159834
Price: 28.38 USD
Availability: InStock
Rating: 4.498600000000001 (20 reviews)

SKU: 463159834

4.5

EUR28.38 EUR78.38

Pay in 4 interest-free payments of $7.09 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 18 - Aug 23

Description

No direct FTC enforcement action against the company itself has been publicly announced as of 2026

The FDAs Zepbound approval announcement also notes that higher-dose tirzepatide produced significant average weight reduction in clinical trials

Instead, it depends on the freedom to explore, to fail, and to follow evidence wherever it leads, because that is where the most transformative breakthroughs are often found